BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28989591)

  • 1. Familial Colorectal Cancer Type X in Central Iran: A New Clinicopathologic Description.
    Zeinalian M; Hadian M; Hashemzadeh-Chaleshtori M; Salehi R; Emami MH
    Int J Hematol Oncol Stem Cell Res; 2017 Jul; 11(3):240-245. PubMed ID: 28989591
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study.
    Bucksch K; Zachariae S; Aretz S; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Kloor M; von Knebel Doeberitz M; Morak M; Möslein G; Nattermann J; Perne C; Rahner N; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vangala DB; Weitz J; Loeffler M; Engel C;
    BMC Cancer; 2020 May; 20(1):460. PubMed ID: 32448342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
    Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
    J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X.
    Bucksch K; Zachariae S; Ahadova A; Aretz S; Büttner R; Görgens H; Holinski-Feder E; Hüneburg R; Kloor M; von Knebel Doeberitz M; Ladigan-Badura S; Moeslein G; Morak M; Nattermann J; Nguyen HP; Perne C; Redler S; Schmetz A; Steinke-Lange V; Surowy H; Vangala DB; Weitz J; Loeffler M; Engel C;
    Int J Cancer; 2022 Jan; 150(1):56-66. PubMed ID: 34469588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemioclinical Feature of Early-Onset Colorectal Cancer at-Risk for Lynch Syndrome in Central Iran.
    Zeinalian M; Hashemzadeh-Chaleshtori M; Akbarpour MJ; Emami MH
    Asian Pac J Cancer Prev; 2015; 16(11):4647-52. PubMed ID: 26107218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of mismatch repair proteins in Iranian colorectal cancer patients at risk for lynch syndrome.
    Zeinalian M; Emami MH; Naimi A; Salehi R; Hashemzadeh-Chaleshtori M
    Iran J Cancer Prev; 2015; 8(1):11-7. PubMed ID: 25821566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinicopathological characteristics of mismatch repair-deficient colorectal carcinoma in early onset cases as compared with late-onset cases: a retrospective cross-sectional study in Northeastern Iran.
    Goshayeshi L; Ghaffarzadegan K; Khooei A; Esmaeilzadeh A; Rahmani Khorram M; Mosannen Mozaffari H; Kiani B; Hoseini B
    BMJ Open; 2018 Aug; 8(8):e023102. PubMed ID: 30166308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microsatellite instability and clinicopathologic features in Iranian colorectal cancer patients at risk for Lynch syndrome.
    Zeinalian M; Hashemzadeh-Chaleshtori M; Salehi R; Kazemi M; Emami MH
    J Res Med Sci; 2015 Feb; 20(2):154-60. PubMed ID: 25983768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary nonpolyposis colorectal cancer and familial colorectal cancer in Central part of Iran, Isfahan.
    Nemati A; Rahmatabadi ZK; Fatemi A; Emami MH
    J Res Med Sci; 2012 Jan; 17(1):67-73. PubMed ID: 23248659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.
    Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P
    Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial colorectal cancer type X: clinical, pathological and molecular characterization].
    Ferreira S; Lage P; Sousa R; Claro I; Francisco I; Filipe B; Suspiro A; Chaves P; Rodrigues P; Albuquerque C; Nobre Leitão C
    Acta Med Port; 2009; 22(3):207-14. PubMed ID: 19686620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L; Goldblatt J; Iacopetta B
    Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
    Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D
    JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center study.
    Signoroni S; Tibiletti MG; Ricci MT; Milione M; Perrone F; Pensotti V; Chiaravalli AM; Carnevali I; Morabito A; Bertario L; Vitellaro M
    Tumori; 2019 Feb; 105(1):76-83. PubMed ID: 30117378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Molecular, Clinicopathological, and Pedigree Differences Between Lynch-Like and Lynch Syndromes.
    Xu Y; Huang Z; Li C; Zhu C; Zhang Y; Guo T; Liu F; Xu Y
    Front Genet; 2020; 11():991. PubMed ID: 32973888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison Between Familial Colorectal Cancer Type X and Lynch Syndrome: Molecular, Clinical, and Pathological Characteristics and Pedigrees.
    Xu Y; Li C; Zhang Y; Guo T; Zhu C; Xu Y; Liu F
    Front Oncol; 2020; 10():1603. PubMed ID: 32984025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of 24 years national surveillance in different hereditary colorectal cancer subgroups leading to more individualised surveillance.
    Lindberg LJ; Ladelund S; Frederiksen BL; Smith-Hansen L; Bernstein I
    J Med Genet; 2017 May; 54(5):297-304. PubMed ID: 28039328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic immunohistochemistry screening for Lynch syndrome in early age-of-onset colorectal cancer patients undergoing surgical resection.
    Steinhagen E; Shia J; Markowitz AJ; Stadler ZK; Salo-Mullen EE; Zheng J; Lee-Kong SA; Nash GM; Offit K; Guillem JG
    J Am Coll Surg; 2012 Jan; 214(1):61-7. PubMed ID: 22192923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancer.
    Shiovitz S; Copeland WK; Passarelli MN; Burnett-Hartman AN; Grady WM; Potter JD; Gallinger S; Buchanan DD; Rosty C; Win AK; Jenkins M; Thibodeau SN; Haile R; Baron JA; Marchand LL; Newcomb PA; Lindor NM;
    Br J Cancer; 2014 Jul; 111(3):598-602. PubMed ID: 24918813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.